🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Gregory A. Daniels

University of California San Diego

ORCID: 0000-0001-9087-8009
MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Combined programmed cell death protein 1 and cytotoxic T-lymphocyte associated protein 4 blockade in an international cohort of patients with acral lentiginous melanoma”.

Combined programmed cell death protein 1 and cytotoxic T-lymphocyte associated protein 4 blockade in an international cohort of patients with acral lentiginous melanoma

British Journal of Dermatology(2024)10.1093/bjd/ljae401
N/A
0.312DataRank · unranked
7 citations

Karam Ashouri, Eftychia Chatziioannou, Jesús Antonio Ocejo Gallegos, Jabra Zarka, Jacob Kechter +39 more

Method for estimation of apoptotic cell fraction of cytotherapy using in vivo fluorine-19 magnetic resonance: pilot study in a patient with head and neck carcinoma receiving tumor-infiltrating lymphocytes labeled with perfluorocarbon nanoemulsion

Journal for ImmunoTherapy of Cancer(2023)10.1136/jitc-2023-007015
N/A
0DataRank · unranked
9 citations

Brooke Helfer, Charles F. O’Hanlon, Deanne Lister, Julie L Bykowski, Karen Messer +6 more

Metastatic gastric cancer target lesion complete response with Claudin18.2-CAR T cells

Journal for ImmunoTherapy of Cancer(2024)10.1136/jitc-2023-007927
N/A
0DataRank · unranked
33 citations

Joseph Chao, H. Ma, Michael G. Hahn, Gloria Sierra, Jie Jia +13 more

Racial Differences in Systemic Immune Parameters in Individuals With Lung Cancer

JTO Clinical and Research Reports(2024)10.1016/j.jtocrr.2024.100751
N/A
0DataRank · unranked
4 citations

Jialiang Liu, Hong Mu-Mosley, Farjana Fattah, Jason Y. Park, Jeffrey A. SoRelle +17 more

Phase 2, Open-Label, Multicenter Study of Nelitolimod in Combination with Pembrolizumab in Anti–PD-1 Treatment-Naïve Advanced Melanoma

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-25-0987
N/A
0DataRank · unranked
5 citations

Mohammed Milhem, Christopher Hoimes, Asim Amin, Cristopher Lao, Robert M. Conry +17 more